{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:59:02Z","timestamp":1791219542253,"version":"4.1.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ijcard.2010.01.004","type":"journal-article","created":{"date-parts":[[2010,4,2]],"date-time":"2010-04-02T04:25:18Z","timestamp":1270182318000},"page":"8-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Should all patients with non-valvular atrial fibrillation be anticoagulated?"],"prefix":"10.1016","volume":"143","author":[{"given":"St\u00e9phane","family":"Ederhy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislaine","family":"Dufaitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Boyer-Chatenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Meuleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Di Angelantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Boccara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2010.01.004_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib3","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.107.501825","article-title":"Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation","volume":"39","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.01.004_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)","volume":"151","author":"Gage","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2010.01.004_bib5","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.01.004_bib6","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","article-title":"Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Singer","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2010.01.004_bib7","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","article-title":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-116-1-1","article-title":"Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk","volume":"116","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib9","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2010.01.004_bib10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","article-title":"A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study","volume":"290","author":"Wang","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2010.01.004_bib11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jacc.2007.09.065","article-title":"Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation","volume":"51","author":"Fang","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib12","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/STROKEAHA.106.477133","article-title":"Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?","volume":"38","author":"Baruch","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.01.004_bib13","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000267275.68538.8d","article-title":"Independent predictors of stroke in patients with atrial fibrillation: a systematic review","volume":"69","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ijcard.2010.01.004_bib14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","article-title":"Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I\u2013III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators","volume":"30","author":"Hart","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.01.004_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.STR.26.5.801","article-title":"Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and with nonrheumatic atrial fibrillation. European Atrial Fibrillation Trial (EAFT) Study Group","volume":"26","author":"van Latum","year":"1995","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.01.004_bib16","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/archinte.158.12.1316","article-title":"Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials","volume":"158","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib17","doi-asserted-by":"crossref","first-page":"194S","DOI":"10.1378\/chest.119.1_suppl.194S","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"119","author":"Albers","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2010.01.004_bib18","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.163.8.936","article-title":"A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin","volume":"163","author":"van Walraven","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib19","series-title":"Atrial fibrillation: national clinical guideline for management in primary and secondary care","year":"2006"},{"key":"10.1016\/j.ijcard.2010.01.004_bib20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2010.01.004_bib21","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/01.CIR.92.4.835","article-title":"Left atrial size and the risk of stroke and death. The Framingham Heart Study","volume":"92","author":"Benjamin","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.01.004_bib22","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.89.2.724","article-title":"Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study","volume":"89","author":"Vaziri","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.01.004_bib23","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0735-1097(98)00146-6","article-title":"Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators","volume":"31","author":"Zabalgoitia","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib24","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.amjcard.2004.11.005","article-title":"Comparison of transesophageal echocardiographic identification of embolic risk markers in patients with lone versus non-lone atrial fibrillation","volume":"95","author":"Di Angelantonio","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib25","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/hc4901.101760","article-title":"C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation","volume":"104","author":"Chung","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.01.004_bib26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.amjcard.2004.04.070","article-title":"Predictive value of indexes of inflammation and hypercoagulability on success of cardioversion of persistent atrial fibrillation","volume":"94","author":"Conway","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib27","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jacc.2006.12.042","article-title":"Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis","volume":"49","author":"Liu","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.amjcard.2008.02.066","article-title":"Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation","volume":"101","author":"Liu","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1161\/01.STR.0000260090.90508.3e","article-title":"High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis","volume":"38","author":"Lip","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.01.004_bib30","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2004.06.011","article-title":"Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation","volume":"94","author":"Thambidorai","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jacc.2004.09.045","article-title":"Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation","volume":"45","author":"Ellinor","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib32","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0735-1097(00)00627-6","article-title":"A cross-sectional and diurnal study of thrombogenesis among patients with chronic atrial fibrillation","volume":"35","author":"Li-Saw-Hee","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib33","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.0000033220.97592.9A","article-title":"Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors","volume":"106","author":"Conway","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.01.004_bib34","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.STR.0000236840.00467.84","article-title":"Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation","volume":"37","author":"Lip","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.01.004_bib35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/hrt.77.5.407","article-title":"Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation","volume":"77","author":"Heppell","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2010.01.004_bib36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1378\/chest.126.3.687","article-title":"Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism","volume":"126","author":"Inoue","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2010.01.004_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.mbc.0000114440.81125.bd","article-title":"D-dimer can predict survival in patients with chronic atrial fibrillation","volume":"15","author":"Mahe","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ijcard.2010.01.004_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijcard.2005.05.049","article-title":"D-dimer level influences thromboembolic events in patients with atrial fibrillation","volume":"109","author":"Nozawa","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib39","first-page":"CD001938","article-title":"Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter","author":"Segal","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijcard.2010.01.004_bib40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.thromres.2004.11.025","article-title":"Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal","volume":"117","author":"Oden","year":"2006","journal-title":"Thromb Res"},{"key":"10.1016\/j.ijcard.2010.01.004_bib41","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib42","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2006.07.034","article-title":"Death and disability from warfarin-associated intracranial and extracranial hemorrhages","volume":"120","author":"Fang","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib43","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjmed.2005.02.022","article-title":"Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall","volume":"118","author":"Gage","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib44","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1161\/01.STR.0000208294.46968.a4","article-title":"Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation","volume":"37","author":"Birman-Deych","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.01.004_bib45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archinternmed.2007.23","article-title":"Risk of thromboembolism with short-term interruption of warfarin therapy","volume":"168","author":"Garcia","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib46","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.01.004_bib47","doi-asserted-by":"crossref","first-page":"160S","DOI":"10.1378\/chest.08-0670","article-title":"Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Ansell","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2010.01.004_bib48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archinte.168.12.1261","article-title":"Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis","volume":"168","author":"Akl","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib49","first-page":"CD006466","article-title":"Oral anticoagulation for prolonging survival in patients with cancer","author":"Akl","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijcard.2010.01.004_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","article-title":"Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin","volume":"105","author":"Beyth","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archinte.159.5.457","article-title":"Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism","volume":"159","author":"Kuijer","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib52","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/s-0037-1615599","article-title":"Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study","volume":"85","author":"Pengo","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ijcard.2010.01.004_bib53","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archinte.160.4.470","article-title":"Oral anticoagulation treatment in the elderly: a nested, prospective, case\u2013control study","volume":"160","author":"Palareti","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib54","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/STROKEAHA.108.526988","article-title":"Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators","volume":"40","author":"van Walraven","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.01.004_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"Singer","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib56","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archinte.160.1.41","article-title":"Why do patients with atrial fibrillation not receive warfarin?","volume":"160","author":"Bungard","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib57","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/archinte.161.20.2458","article-title":"Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting","volume":"161","author":"McCormick","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib58","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0002-9149(99)00813-9","article-title":"Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center","volume":"85","author":"Bradley","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/clc.4960251003","article-title":"Anticoagulants for atrial fibrillation: why is the treatment rate so low?","volume":"25","author":"Buckingham","year":"2002","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib60","first-page":"1775","article-title":"A community survey of patients with atrial fibrillation: associated disabilities and treatment preferences","volume":"48","author":"Sudlow","year":"1998","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.ijcard.2010.01.004_bib61","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/01.CIR.99.23.3028","article-title":"Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists","volume":"99","author":"Levy","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.01.004_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bmj.326.7381.153","article-title":"Anticoagulation in hospitals and general practice","volume":"326","author":"Blann","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2010.01.004_bib63","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2005.06.077","article-title":"Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation","volume":"46","author":"Waldo","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib64","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","volume":"104","author":"Fuster","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2010.01.004_bib65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0002-8703(03)00524-6","article-title":"Cost of care distribution in atrial fibrillation patients: the COCAF study","volume":"147","author":"Le Heuzey","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2010.01.004_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pds.1329","article-title":"Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France","volume":"16","author":"Leizorovicz","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ijcard.2010.01.004_bib67","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1093\/eurheartj\/ehl015","article-title":"Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation","volume":"27","author":"Nieuwlaat","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2010.01.004_bib68","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ahj.2007.03.008","article-title":"Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation","volume":"153","author":"Nieuwlaat","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2010.01.004_bib69","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0735-1097(00)01178-5","article-title":"Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation","volume":"37","author":"Klein","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib70","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1540-8175.2007.00344.x","article-title":"Warfarin therapy initiated before is more beneficial than after transesophageal echocardiography detected left atrial thrombus","volume":"24","author":"Shen","year":"2007","journal-title":"Echocardiography"},{"key":"10.1016\/j.ijcard.2010.01.004_bib71","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib72","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0735-1097(02)01785-0","article-title":"Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study","volume":"39","author":"Seidl","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib73","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehl353","volume":"27","author":"Klein","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2010.01.004_bib74","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.STR.0000254719.26536.a9","article-title":"Stroke prevention in atrial fibrillation: pharmacological rate versus rhythm control","volume":"38","author":"Sherman","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.01.004_bib75","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archinte.165.3.258","article-title":"Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis","volume":"165","author":"de Denus","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib76","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1093\/eurheartj\/ehi306","article-title":"Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis","volume":"26","author":"Testa","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2010.01.004_bib77","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib78","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib79","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(00)03230-X","article-title":"Rhythm or rate control in atrial fibrillation\u2013Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial","volume":"356","author":"Hohnloser","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2010.01.004_bib80","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0735-1097(03)00332-2","article-title":"Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study","volume":"41","author":"Carlsson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib81","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib82","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1378\/chest.126.2.476","article-title":"Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study","volume":"126","author":"Opolski","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2010.01.004_bib83","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archinte.165.10.1185","article-title":"Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study","volume":"165","author":"Sherman","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib84","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","article-title":"Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators","volume":"35","author":"Hart","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib85","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/eurheartj\/ehn101","article-title":"Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation?","volume":"29","author":"Nieuwlaat","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2010.01.004_bib86","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jacc.2007.07.076","article-title":"Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy","volume":"50","author":"Hohnloser","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib87","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/01.STR.23.4.486","article-title":"Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism","volume":"23","author":"Timsit","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2010.01.004_bib88","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(00)02085-7","article-title":"Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial","volume":"355","author":"Berge","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2010.01.004_bib89","first-page":"CD003242","article-title":"Anticoagulants versus antiplatelet agents for acute ischaemic stroke","author":"Berge","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijcard.2010.01.004_bib90","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jacc.2007.10.043","article-title":"Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery","volume":"51","author":"Echahidi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2010.01.004_bib91","first-page":"CD005158","article-title":"Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease","author":"Keller","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijcard.2010.01.004_bib92","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib93","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/eurheartj\/ehm575","article-title":"New oral anticoagulants in atrial fibrillation","volume":"29","author":"Turpie","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2010.01.004_bib94","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2010.01.004_bib95","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2010.01.004_bib96","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.echo.2004.12.003","article-title":"Cardiovascular death in patients with atrial fibrillation is better predicted by left atrial thrombus and spontaneous echocardiographic contrast as compared with clinical parameters","volume":"18","author":"Dawn","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ijcard.2010.01.004_bib97","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1052-3057(10)80166-1","article-title":"Stroke Prevention in Atrial fibrillation. Risk factors for thrombo embolism during aspirin therapy in patients with atrial fibrillation: the stroke prevention in atrial fibrillation study","volume":"5","year":"1995","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.ijcard.2010.01.004_bib98","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2008.11.048","article-title":"Ethical authorship and publishing","volume":"131","author":"Coats","year":"2009","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527310000240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527310000240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:25:33Z","timestamp":1759091133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527310000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0167527310000240"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2010.01.004","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should all patients with non-valvular atrial fibrillation be anticoagulated?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2010.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}